{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:11:59Z","timestamp":1788966719634,"version":"build-2803163510"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background and purpose:<\/jats:title>\n                    <jats:p>Cholestasis or bile duct ligation (BDL) could develop cirrhosis and may lead to other organ dysfunction, including the kidneys, which is called cholemic nephropathy (CN). Hyperbilirubinemia, bile acid accumulation, renal hypoperfusion, oxidative stress, and inflammation are implicated in the pathogenesis of CN. Sitagliptin is an oral antihyperglycemic drug with anti-inflammatory and anti-oxidative effects. Its effects on CN were unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental approach:<\/jats:title>\n                    <jats:p>The BDL-induced CN model was performed in 35 male Wistar rats (200-250 g), which were divided into five groups (n = 7) as follows: sham group receiving distilled water as vehicle (sham + Veh), BDL group receiving vehicle (BDL + Veh), and BDL groups receiving sitagliptin at the doses of 10, 50, or 100 mg\/kg\/day by gavage for 14 days named BDL + Sit 10, BDL + Sit 50, and BDL + Sit 100, respectively. Aspartate transferase, alkaline phosphatase, total bilirubin (T-Bil), renal function biomarkers, creatinine (Cr) clearance, redox system status, TNF-\u03b1, and renal histopathology were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings\/Results:<\/jats:title>\n                    <jats:p>BDL increased serum liver enzymes, T-Bil, Cr, urea, urine Cr, albumin to Cr ratio, and decreased Cr clearance. Also, BDL elevated renal sestrin2, malondialdehyde, TNF-\u03b1, renal index, and kidney tissue injury score, while reducing superoxide dismutase (SOD) activity, total antioxidant capacity, and nuclear factor erythroid 2-related factor 2 (Nrf2). Sitagliptin, especially at the low dose, reversed these effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and implications:<\/jats:title>\n                    <jats:p>\n                      Sitagliptin improved renal injury and function\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      ameliorating inflammation and oxidative stress by activating the Nrf2\/SOD pathway in BDL rats. Sitagliptin might help treat renal complications in cirrhosis and liver diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/rps.rps_101_25","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:05Z","timestamp":1788949145000},"page":"605-617","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Sitagliptin protects against bile duct ligation-induced cholemic nephropathy in male rats through modulation of inflammation, sestrin2, and the Nrf2\/SOD pathway"],"prefix":"10.4103","volume":"21","author":[{"given":"Mohammad","family":"Akhbari","sequence":"first","affiliation":[{"name":"Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadan","family":"Saberi","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran"},{"name":"Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khaksari","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism Research Center, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Askaripour","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, Bam University of Medical Sciences, Bam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[{"name":"Department of Pathology, Pathology and Stem Cell Research Center, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"9398","key":"R1-20260909","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e9s","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"R2-20260909","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"R3-20260909","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1080\/07853890.2021.1998595","article-title":"Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018","volume":"53","author":"Singh","year":"2021","journal-title":"Ann Med"},{"issue":"7","key":"R4-20260909","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","article-title":"Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites","volume":"8","author":"Montoliu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"R5-20260909","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"R6-20260909","first-page":"217","article-title":"Antioxidant and hepatoprotective activities of Juniperus excelsa M","volume":"19","author":"Akbari","year":"2024","journal-title":"Bieb against bile duct ligation-induced cholestasis. Res Pharm Sci"},{"issue":"8","key":"R7-20260909","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S0102-86502012000800013","article-title":"Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection","volume":"27","author":"Marques","year":"2012","journal-title":"Acta Cir Bras"},{"issue":"6","key":"R8-20260909","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/hep.26599","article-title":"Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice","volume":"58","author":"Fickert","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"R9-20260909","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mcna.2013.09.002","article-title":"Cholestatic liver disease","volume":"98","author":"Gossard","year":"2014","journal-title":"Med Clin North Am"},{"issue":"12","key":"R10-20260909","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2174\/1871530321666211125102924","article-title":"Bilirubin and epigenetic modifications in metabolic and immunometabolic disorders","volume":"22","author":"Moradi Sarabi","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"6","key":"R11-20260909","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00210-020-02040-8","article-title":"Silymarin mitigates bile duct obstruction-induced cholemic nephropathy","volume":"394","author":"Ommati","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"R12-20260909","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/ceh.2021.104675","article-title":"Taurine mitigates bile duct obstruction- associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters","volume":"7","author":"Abdoli","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"R13-20260909","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2021.05.012","article-title":"The inhibition of NF\u03baB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity","volume":"349","author":"Ahmadi","year":"2021","journal-title":"Toxicol Lett"},{"issue":"6","key":"R14-20260909","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"R15-20260909","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","article-title":"Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis","volume":"59","author":"Fagundes","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"R16-20260909","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/jhep.2001.29200","article-title":"New challenge of hepatorenal syndrome: prevention and treatment","volume":"34","author":"Wong","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"R17-20260909","doi-asserted-by":"crossref","first-page":"134,1","DOI":"10.1038\/s41598-022-27301-9","article-title":"Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study","volume":"13","author":"Nagao","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"R18-20260909","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Eng J Med"},{"key":"R19-20260909","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabres.2016.06.020","article-title":"The effect of dipeptidyl peptidase- IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus","volume":"118","author":"Sromova","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"R20-20260909","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.toxlet.2025.07.1418","article-title":"Gentamicin aggravates renal injury by affecting mitochondrial dynamics, altering renal transporter expression, and exacerbating apoptosis","volume":"412","author":"Zhang","year":"2025","journal-title":"Toxicol Lett"},{"issue":"4","key":"R21-20260909","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jphp.12534","article-title":"Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin-induced nephrotoxicity","volume":"68","author":"Abuelezz","year":"2016","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"R22-20260909","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2478\/dine-2021-0007","article-title":"Sitagliptin ameliorates ER stress in diabetic kidney disease through upregulation of SIRT1","volume":"1","author":"Zhang","year":"2021","journal-title":"Diabetic Nephropathy"},{"issue":"12","key":"R23-20260909","doi-asserted-by":"crossref","first-page":"e0226430,1","DOI":"10.1371\/journal.pone.0226430","article-title":"Oxygen inhalation improves postoperative survival in ketamine-xylazine anaesthetised rats: an observational study","volume":"14","author":"Mechelinck","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"R24-20260909","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.24047","article-title":"Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells","volume":"53","author":"He","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"R25-20260909","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/aps.2014.98","article-title":"Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors","volume":"36","author":"Chang","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"R26-20260909","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jneumeth.2010.03.029","article-title":"Ketamine anesthesia helps preserve neuronal viability","volume":"189","author":"de Oliveira","year":"2010","journal-title":"J Neurosci Methods"},{"key":"R27-20260909","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.freeradbiomed.2013.10.005","article-title":"Metabolic syndrome-induced tubulointerstitial injury: role of oxidative stress and preventive effects of acetaminophen","volume":"65","author":"Wang","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"R28-20260909","doi-asserted-by":"crossref","first-page":"209","DOI":"10.33549\/physiolres.934784","article-title":"Pathophysiological analysis of uninephrectomized db\/db mice as a model of severe diabetic kidney disease","volume":"71","author":"Maekawa","year":"2022","journal-title":"Physiol Res"},{"issue":"1","key":"R29-20260909","first-page":"32","article-title":"Daidzein mitigates oxidative stress and inflammation in the injured kidney of ovariectomized rats: AT1 and Mas receptor functions","volume":"16","author":"Askaripour","year":"2022","journal-title":"Iran J Kidney Dis"},{"issue":"5","key":"R30-20260909","doi-asserted-by":"crossref","first-page":"127,1","DOI":"10.1007\/s13205-024-03970-3","article-title":"Exploring the antioxidant potential of endophytic fungi: a review on methods for extraction and quantification of total antioxidant capacity (TAC)","volume":"14","author":"Asomadu","year":"2024","journal-title":"3 Biotech"},{"key":"R31-20260909","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.crphar.2020.100006","article-title":"Suppression of cirrhosis- related renal injury by N-acetyl cysteine","volume":"1","author":"Abdoli","year":"2020","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"4","key":"R32-20260909","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5114\/ceh.2021.111014","article-title":"Pentoxifylline mitigates cholestasis-related cholemic nephropathy","volume":"7","author":"Ommati","year":"2021","journal-title":"Clin Exp Hepatol"},{"issue":"4 Pt B","key":"R33-20260909","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","article-title":"Heart and bile acids-clinical consequences of altered bile acid metabolism","volume":"1864","author":"Vasavan","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R34-20260909","doi-asserted-by":"crossref","first-page":"100212","DOI":"10.1016\/j.phanu.2020.100212","article-title":"Agmatine alleviates hepatic and renal injury in a rat model of obstructive jaundice","volume":"13","author":"Ommati","year":"2020","journal-title":"PharmaNutrition"},{"issue":"5","key":"R35-20260909","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4103\/RPS.RPS_184_24","article-title":"Nephroprotective effects of ethanol leaf extract of Stachys pilifera Benth in alcohol-induced nephrotoxicity in male rats","volume":"20","author":"Taheri Mirghaed","year":"2025","journal-title":"Res Pharm Sci"},{"issue":"3","key":"R36-20260909","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/1735-5362.371582","article-title":"Sodium hydrogen sulfide may not protect the kidney against ischemia\/reperfusion damage in male and female rats","volume":"18","author":"Askaripour","year":"2023","journal-title":"Res Pharm Sci"},{"issue":"10","key":"R37-20260909","doi-asserted-by":"crossref","first-page":"e22386,1","DOI":"10.1002\/jbt.22386","article-title":"Curcumin synergistically potentiates the protective effect of sitagliptin against chronic deltamethrin nephrotoxicity in rats: impact on pro-inflammatory cytokines and Nrf2\/Ho-1 pathway","volume":"33","author":"Shi","year":"2019","journal-title":"J Biochem Mol Toxicol"},{"key":"R38-20260909","doi-asserted-by":"crossref","first-page":"200, 1","DOI":"10.3389\/fonc.2012.00200","article-title":"The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism","volume":"2","author":"Mitsuishi","year":"2012","journal-title":"Front Oncol"},{"issue":"10","key":"R39-20260909","doi-asserted-by":"crossref","first-page":"928,1","DOI":"10.1038\/s41419-021-04227-0","article-title":"Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury","volume":"12","author":"Kong","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"R40-20260909","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1389557521666210505112834","article-title":"Astaxanthin and Nrf2 signaling pathway: a novel target for new therapeutic approaches","volume":"22","author":"Ashrafizadeh","year":"2022","journal-title":"Mini Rev Med Chem."},{"issue":"11","key":"R41-20260909","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2443.2008.01234.x","article-title":"Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice","volume":"13","author":"Yoh","year":"2008","journal-title":"Genes Cells"},{"issue":"11","key":"R42-20260909","doi-asserted-by":"crossref","first-page":"e0142438,1","DOI":"10.1371\/journal.pone.0142438","article-title":"NRF2 regulates PINK1 expression under oxidative stress conditions","volume":"10","author":"Murata","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"R43-20260909","doi-asserted-by":"crossref","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","article-title":"Contribution of impaired Nrf2- Keap1 pathway to oxidative stress and inflammation in chronic renal failure","volume":"298","author":"Kim","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"R44-20260909","doi-asserted-by":"crossref","first-page":"1940,1","DOI":"10.3390\/ijms20081940","article-title":"Cardioprotection conferred by sitagliptin is associated with reduced cardiac angiotensin II\/angiotensin-(1-7) balance in experimental chronic kidney disease","volume":"20","author":"Beraldo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"R45-20260909","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1463-1326.2004.00430.x","article-title":"Function of a long-term, GLP-1-treated, insulin-secreting cell line is improved by preventing DPP IV-mediated degradation of GLP-1","volume":"7","author":"Green","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"R46-20260909","doi-asserted-by":"crossref","first-page":"840142,1","DOI":"10.3389\/fonc.2022.840142","article-title":"Association between DPP-4 inhibitors and events of colorectal and liver cancers in patients with diabetes receiving second-line agents: a nested case- control study","volume":"12","author":"Chou","year":"2022","journal-title":"Front Oncol"},{"key":"R47-20260909","doi-asserted-by":"crossref","first-page":"538737,1","DOI":"10.1155\/2014\/538737","article-title":"Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals","volume":"2014","author":"Marques","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"3","key":"R48-20260909","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1159\/000490688","article-title":"Anti-inflammatory action of sitagliptin and linagliptin in doxorubicin nephropathy","volume":"43","author":"Jo","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"R49-20260909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e114441","article-title":"Kidney protective effect of sitagliptin in 5-fluorouracil-challenged rats","volume":"71","author":"Al-Ghamdi","year":"2024","journal-title":"Pharmacia"},{"key":"R50-20260909","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopha.2018.11.117","article-title":"The renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in rats","volume":"110","author":"Abdelrahman","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"R51-20260909","doi-asserted-by":"crossref","first-page":"6532,1","DOI":"10.3390\/ijms24076532","article-title":"Sitagliptin mitigates diabetic nephropathy in a rat model of streptozotocin-induced type 2 diabetes: Possible role of PTP1B\/JAK-STAT pathway","volume":"24","author":"Al-Qabbaa","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"R52-20260909","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/0886022X.2015.1010991","article-title":"Protective effect of sitagliptin against renal ischemia reperfusion injury in rats","volume":"37","author":"Nuransoy","year":"2015","journal-title":"Ren Fail"},{"key":"R53-20260909","doi-asserted-by":"crossref","first-page":"346,1","DOI":"10.1186\/s40064-015-1135-z","article-title":"Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury","volume":"4","author":"Asakawa","year":"2015","journal-title":"Springerplus"},{"issue":"7","key":"R54-20260909","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/a-1186-0841","article-title":"Effects and safety of sitagliptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"52","author":"Zhang","year":"2020","journal-title":"Horm Metab Res"},{"issue":"12","key":"R55-20260909","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00125-024-06265-7","article-title":"The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial","volume":"67","author":"Elbarbary","year":"2024","journal-title":"Diabetologia"},{"issue":"3","key":"R56-20260909","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.07.053","article-title":"A dipeptidyl peptidase- 4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"59","author":"Matsubara","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"R57-20260909","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/HYPERTENSIONAHA.114.03840","article-title":"Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production","volume":"64","author":"Yang","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"R58-20260909","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s12276-022-00737-9","article-title":"Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome- mediated pyroptosis","volume":"54","author":"Han","year":"2022","journal-title":"Exp Mol Med."}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_101_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:20:01Z","timestamp":1788963601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_101_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/rps.rps_101_25","relation":{},"ISSN":["1735-5362","1735-9414"],"issn-type":[{"value":"1735-5362","type":"print"},{"value":"1735-9414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-06-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}